Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cronos Australia Ltd. ( (AU:VIT) ) has issued an announcement.
Vitura Health Limited held its 2025 Annual General Meeting, where three resolutions were passed, and one was withdrawn. The meeting highlighted the company’s strategic focus on expanding its digital health platform and integrating new opportunities such as psychedelic product distribution, reinforcing its position in the medicinal cannabis and telehealth markets.
More about Cronos Australia Ltd.
Vitura Health Limited is a diversified digital health business listed on the ASX, operating through subsidiaries such as Burleigh Heads Cannabis, Canview, Doctors on Demand, Cortexa, CDA Clinics, and Cannadoc Health. The company focuses on the sale and distribution of medicinal cannabis and other therapeutic products, leveraging a comprehensive online ecosystem for prescribers, patients, and pharmacies. Vitura is also involved in telehealth services and aims to be a leading supplier of psychedelics for research and therapeutic use in Australia.
Average Trading Volume: 223,440
Technical Sentiment Signal: Sell
Current Market Cap: A$42.42M
Learn more about VIT stock on TipRanks’ Stock Analysis page.